Literature DB >> 1301487

[Evaluation of the effectiveness of cisapride in the treatment of gastroesophageal reflux].

G Iacono1, A Carroccio, G Montalto, F Cavataio, D Lorello, M Soresi, I Kazmierska, V Balsamo.   

Abstract

To evaluate the effectiveness of administration of oral cisapride in patients with gastro-esophageal reflux, we studied 25 children, aged 1 month-7 years (mean 16.2 months) affected with GER. At the time of diagnosis and 8 weeks after treatment, patients were clinically evaluated and underwent a 24-hour continuous esophageal pH-monitoring. After treatment a complete regression of symptoms was observed in 20/25 patients. Moreover we recorded a significant reduction in the percentage of reflux time (p < 0.0001) and in the Jolley score (p < 0.0001), a very accurate scoring system to evaluate the pH-metric tracing, after treatment. It is concluded that cisapride is a useful agent both for the relief of symptoms and for the improvement of pH-metric parameters in children with GER disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1301487

Source DB:  PubMed          Journal:  Minerva Pediatr        ISSN: 0026-4946            Impact factor:   1.312


  4 in total

1.  Varicella: to vaccinate or not to vaccinate?

Authors:  A Gershon
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

2.  Diagnosis and treatment of gastroesophageal reflux disease in infants and children.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

3.  The risks and benefits of cisapride in premature neonates, infants, and children.

Authors:  A Lander; A Desai
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

Review 4.  Efficacy and tolerability of cisapride in children.

Authors:  Y Vandenplas; A Benatar; F Cools; A Arana; B Hegar; B Hauser
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.